Publisher： Blackwell Publishing
E-ISSN： 1097-0142|121|14|2350-2357
ISSN： 0008-543X
Source： Cancer, Vol.121, Iss.14, 2015-07, pp. : 2350-2357
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Long-term androgen deprivation should be `standard treatment'
Inpharma, Vol. 1, Iss. 1635, 2008-01 ,pp. :
Access to resources
Recommend
Increased fracture risk with androgen-deprivation therapy
Reactions Weekly, Vol. 1, Iss. 1035, 2005-01 ,pp. :
Toremifene a strong option in androgen-deprivation therapy
Inpharma, Vol. 1, Iss. 1635, 2008-01 ,pp. :
Longterm androgen deprivation therapy has a cost
Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. :
Long-term androgen suppression impact on QOL "acceptable"
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 579, 2009-01 ,pp. :